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Abstract
Background: The purpose of the study was to determine the anti-melanogenic and anti-oxidant properties of
Gaillardia aristata flower extract (GAE).
Methods: Melanogenesis inhibition by GAE was investigated in cultivated cells and in a human skin model. In
cultivated cells, the melanogenesis regulatory effect of GAE was evaluated using melanin content, intracellular
tyrosinase activity and anti-oxidant characteristics. In addition, the expression of melanogenesis-related proteins
was determined by western blot assay and real-time PCR.
Results: GAE reduced the amount of melanin in B16F10 and normal human epidermal melanocyte cells and suppressed
intracellular tyrosinase activity in a dose-dependent pattern. Also, GAE significantly decreased the expression of
melanogenesis-related proteins (microphthalmia associated transcription factor, tyrosinase, tyrosinase-related protein-1,
and dopachrome tautomerase). Real-time PCR results revealed a down-regulation of the mRNAs of these proteins. GAE
possessed anti-oxidant characteristics as free radical-scavenging capacity and reducing power. In the three-dimensional
human skin model, GAE applied to hyperpigmented skin significantly increased the degree of skin lightening within
2 weeks of treatment. The safety of GAE on human skin was confirmed.
Conclusions: These results indicate the potential of GAE for use in suppressing skin pigmentation. We proposed GAE as
a new candidate of anti-melanogenic and antioxidant agents that could be used for cosmetic skin care products.
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Background
Melanin secreted by melanocytes is the major pigment
of human skin color in the basal layer of the epidermis.
Melanin is crucial in photo-protection of human skin
from harmful ultraviolet (UV) sunlight damage [1].
However, various hyperpigmented skin disorders result
from the overproduction and subsequent accumulation
of melanin, such as freckles, age spots, melanoderma,
and senile lentigo, can be a distressing problem [2]. In
melanin biosynthesis, the copper containing tyrosinase
(TYR) enzyme catalyzes the hydroxylation of L-tyrosine
to L-3,4-dihydroxyphenylalanine (L-DOPA) and the oxi-
dation of L-DOPA to o-dopaquinone [3]. Microphthalmia
associated transcription factor (MITF), tyrosinase-related
protein-1 (TRP-1), and DCT are also essential for the
production of melanin [4].
Melanogenesis produces the reactive oxidants including
hydrogen peroxide (H2O2) and reactive oxygen species
(ROS), which create oxidative stress in melanocytes.
Certain ROS scavengers and inhibitors of ROS generation
inhibit UV-induced melanogenesis and antioxidants like
reduced glutathione (GSH) and ascorbic derivatives are
applied to treat various skin problems such as depigmen-
tation of hyperpigmented spots [5, 6]. Hence, antioxidants
and free radical scavengers also play an important role in
protecting human skin from the harmful effects by UV
radiation as hyperpigmentation [7]. Development of effect-
ive anti-melanogenic agents with antioxidative capacity is a
promising strategy to prevent or improve skin against
damage due to UV radiation.
Depigmenting agents, such as arbutin [8] and kojic
acid, have been used instead of hydroquinone to help
prevent skin darkening. However, these compounds have
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undesirable side effects and can be weakly active [9–11].
Thus, it is important to develop new depigmenting
agents as inhibitors of melanin formation that are derive
from natural sources, which will lessen the likelihood of
unrelated cytotoxicity or other side effects [12, 13].
In a preliminary study, we screened many herbal
extracts for new melanogenesis inhibitors. The ethanol
extract of Gaillardia aristata, a native plant in the
sunflower family with a widespread geographic range and
a prized ornamental plant, displayed strong inhibition of
melanogenesis in B16F10 and HEMa-DP cells. The plant
has a history of use in treating wounds and fever by
Plateau Indian tribes [14].
Melanogenesis inhibition by G. aristata ethanol extract
(GAE) has not been previously reported. We were particu-
larly interested in its potential cosmetic applications. This
study aimed to determine the antioxidative characteristics
and the inhibitory effect of GAE on melanogenesis in




Kojic acid, arbutin, α-MSH, 3,4-dihydroxyphenilalanine (L-
DOPA), tyrosine, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-
tetrazolium bromide (MTT), diphenyl-1-picrylhydrazyl
(DPPH), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic
acid (ABTS), and dimethyl sulfoxide (DMSO) were
purchased from Sigma-Aldrich (St Louis, MO, U.S.A.).
Antibodies against TYR, TRP-1, DCT and MITF were
obtained from Santa Cruz Biotechnology (Santa Cruz, CA,
U.S.A.). Recombinant human stem cell factor (SCF) was
supplied by ProSpec-Tany (Rehovot, Israel).
Preparation of GAE
G. aristata flower seeds were perchased from wonyejong-
myo (Korea) and we cultivated it in Jeju Island, Korea. After
harvesting from July to August, the powdered Gaillardia
aristata flower (28.9 g) was extracted overnight with 5 L of
70 % ethanol at room temperature and the supernatant was
collected by filtration. Ethanol was removed by rotary
vacuum evaporation (EYELA, Tokyo, Japan) and the extract
(8.4 g) was lyophilized.
DPPH scavenging activity assay
The antioxidant activity of GAE was first determined by
measuring the DPPH scavenging ability [15]. The extract
at various concentrations (25, 50, 100, 250, 500, and
1000 μg/mL) was added to 200 μL of DPPH (100 μM)
solution. DPPH reaction with an antioxidant capable of
hydrogen ion donation reduces DPPH. The resulting
decrease in absorbance at 540 nm was recorded using a
Gen 5™ UV-Vis spectrophotometer (BioTek, Winooski,
VT, U.S.A.).
ABTS+ scavenging capacity assay
The ABTS decolorization assay was done as previously
described [16]. The assay relies on the generation of
ABTS+ chromophore by oxidation of ABTS with potas-
sium persulfate. The ABTS radical cation (ABTS+) was
produced by reacting 7 mM stock solution of ABTS with
2.45 mM potassium persulfate and allowing the mixture
to stand in the dark for at least 6 h before use. Absorbance
at 734 nm was measured 30 min after the mixing of
various concentrations of GAE (25, 50, 100, 250, 500,
1000 μg/mL) with 1 mL of ABTS+ solution.
Determination of reducing capacity
The reducing power of the extract was determined as pre-
viously described [17]. The FRAP reagent was produced
by mixing 300 mM acetate buffer (pH 3.6), 10 mM TPTZ
solution, and 20 mM FeCl3⋅6H2O in a 10 : 1 : 1 ration and
was prepared freshly at 37 °C. Different concentrations of
GAE (25, 50, 100, 250, 500, and 1000 μg/mL) were
individually mixed with FRAP reagent. The mixture was
incubated at room temperature for 30 min in dark. The
absorbance was measured at 595 nm in the UV-Vis spec-
trophotometer. Higher absorbance of the reaction mixture
indicated greater reducing power.
Determination of total phenolic content
Total phenolics were determined by an established assay
[18]. Gallic acid was used to plot a standard curve. Various
concentrations of GAE (50, 100, and 200 μg/mL) or gallic
acid (50 and 100 μg/mL) dissolved in alkaline copper
reagent was mixed with copper sulfate reagent, sodium
dodecyl sulfate (SDS) solution, and sodium hydroxide so-
lution in a 1:2:1 ratio, and incubated at room temperature.
After 10 min, 0.5 mL of diluted Folin-Ciocalteu phenol
reagent was added and then incubated for 30 min at room
temperature. The absorbance of samples was measured
750 nm.
Cell culture
B16F10 melanoma cells were cultured in Dulbecco's
Modified Eagle's Medium (DMEM; Hyclone, Logan, UT,
U.S.A.) with 10 % fetal bovine serum and penicillin/
streptomycin (100 IU/50 μg/mL) in a humidified atmos-
phere containing 5 % CO2 in air at 37 °C. Primary cultures
of normal human epidermal melanocytes (HEMa-DP;
Cascade Biologics, Portland, OR, U.S.A.) derived from
neonatal foreskin were cultured in Medium-254 (Cascade
Biologics) supplemented with human melanocyte growth
supplement (HMGS; Cascade Biologics) in a humidified
atmosphere containing 5 % CO2 and 95 % air at 37 °C.
Cell viability assay
Cell viability was determined by an established MTT-
based assay. B16F10 melanoma cells and HEMa-DP cells
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were incubated with GAE for 5 days. Following
treatment with MTT solution (1 mg/mL in phosphate
buffered saline, PBS), the cells were incubated at 37 °C
for 2 h. DMSO was added after the media was discarded
and the absorbance was measured at 570 nm using the
aforementioned a spectrophotometer.
Determination of melanin content
B16F10 cells were first treated with GAE (10 and
20 μg/mL) in DMEM medium for 2 h followed by alpha-
melanocyte-stimulating hormone (α–MSH; 50 nM) for an
additional 72 h. HEMa-DP cells were incubated with GAE
for 96 h. The cells were washed with PBS and lysed with
1 N NaOH for 1 h at 60 °C. Melanin content was
estimated by the absorbance at 450 nm. Results were
confirmed by three independent experiments. Before
measuring the melanin content, cells were observed using
a model TS-100 phase contract microscope (Nikon,
Tokyo, Japan) and photographed using an attached TCH-
5.0ICE digital camera (TUCSEN, Fujian, China) supported
by ScopePhoto softeware (TUCSEN).
Measurement of cellular tyrosinase activity
B16F10 cells were seeded at a density of 5 × 104 cells per
well in 6-well culture plates and incubated for 24 h.
They were first treated with GAE for 2 h and then stim-
ulated with 50 nM α-MSH for an additional 72 h.
HEMa-DP cells were treated with GAE (10 and 20 μg/
mL) and incubated for 5 days. The treated cells were
washed twice using PBS and lysed with lysis buffer. Cell
lysates were clarified by centrifugation at 5,000 rpm for
15 min at 4 °C. Enzyme activity was normalized to pro-
tein concentration, as determined by the Bradford assay.
The cellular Tyrosinase and L-DOPA solution (0.1 M in
sodium phosphate buffer) reaction were performed at 37 °C
for 1 h. The absorbance at 450 nm was measured
using the aforementioned spectrophotometer to moni-
tor the production of dopachrome, corrected for
auto-oxidation of L-DOPA.
Tyrosinase zymography
Cultured cells were washed three times with PBS and
harvested with lysis buffer (0.1 M sodium phosphate buf-
fer (pH 6.8), 0.1 % Triton X-100, 1 % protease inhibitor
cocktail). Protein content was determined with a Bradford
assay using bovine serum albumin (BSA) as the standard.
Equal amounts (20 μg) were mixed with sampling
buffer and resolved by 10 % SDS-polyacrylamide gel
electrophoresis. After electrophoresis, the gel contain-
ing tyrosinase activity was incubated with 0.1 M so-
dium phosphate buffer (NaH2PO4, pH 6.8) for 30 min
at room temperature. The gel was incubated in the
dark at 37 °C for 1 h after stained to 5 mM L-DOPA
in 0.1 M sodium phosphate buffer.
Tyrosinase luciferase reporter assay
To assay for tyrosinase promoter activity, B16F10
melanoma cells and HEMa-DP cells were transfected
with tyrosinase reporter along with Renilla luciferase ex-
pression vector driven by the thymidine kinase promoter
(Promega, Madison, WI, U.S.A.) using Superfect™ reagent
(Qiagen, Valencia, CA, U.S.A.). After incubation for 24 h,
cells were treated for 24 h with GAE. The cells were
harvested and lysed, and the supernatants were assayed
for luciferase activity using a Dual Luciferase Assay
System (Promega, Madison, WI, U.S.A.).
Western blotting
To measure melanogenesis pathways, 40 μg total protein
was subjected to electrophoresis on a 10 % Bis-Tris gel
(Invitrogen, Carlsbad, CA, U.S.A.). The resolved proteins
were transferred to a nitrocellulose membrane that was
blocked with 5 % BSA or 5 % skimmed milk in PBST
(0.1 % Tween 20 in PBS) for 1 h. The membrane was
incubated with the select primary antibody followed by
incubation with the appropriate secondary antibody.
Proteins were visualized using PowerOpti-ECL Western
blotting Detection reagent (Anigen, Hwaseong, Korea).
Protein bands were quantified with Image J software.
β-actin were used as an internal control.
Quantitative real-time PCR analysis
Total RNA samples were extracted using a RNeasy Midi
kit (Qiagen) and aliquot (2 μg) of total RNA was reversed
transcribed using a PrimeScriptII 1st strand cDNA
Synthesis kit (Takara Bio, Shiga, Japan) according to the
standard protocol. Quantitative PCR was performed with
RT2 qPCR Primer Assay using the manufacturer’s proto-
col (Qiagen). Real-Time PCR was carried using SYBR
green with the PCR Thermal Cycler MP device (Takara
Bio). Each reaction was performed in triplicate. All human
qRT-PCR primers were pre-designed, validated RT2 qPCR
primer pairs (Qiagen) as follows. For human genes, TYR
(PPH01771F), TRP-1 (PPH01770F), dopachrome tauto-
merase (DCT, PPH16498A), MITF (LPH40195A) and
GAPDH (PPH00150F) were used. Relative gene expres-
sion was normalized to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA and calculated with the
ΔΔCT method.
Histochemistry of reconstructed epidermis
A 3D-human skin tissue model (MatTek, Ashland, MA,
U.S.A.) consisting of normal human-derived epidermal
keratinocytes and normal human epidermal melanocytes
was incubated in Long Life Maintenance medium (EPI-
100-LLMM; MatTek, Ashland, MA, U.S.A.) containing
GAE (100 and 200 μg/mL). The medium was replaced
every 3 days for 14 days. Reconstructed human epidermis
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was fixed in 4 % paraformaldehyde using Fontana-Masson
staining to stain melanin.
Evaluation of inhibitory efficacy of GAE on the 3D-human
skin model
The reconstructed human epidermis (MEL-300-B) was
incubated with 20 nM SCF in the presence of GAE (100
and 200 μg/mL) for 14 days. Human recombinant SCF
was added three times for 14 days. To measure the
degree of pigmentation, L-values were measured using a
CR-300 chromameter (Minolta, Tokyo, Japan).
Human skin primary irritation test
The subject pool consisted of thirty healthy women and
over ranging from 24 to 47 years of age. The subjects
were required to satisfy all of the inclusion criteria and
could not conflict with any of the exclusion criteria.
Exclusion criteria were acute diseases, severe illnesses,
pregnancy or lactation period, sensitization to ingredi-
ents of the test plaster, application of pharmaceutical
products or skin care products with active ingredients
until 4 weeks before testing, intake of drugs that possibly
can interfere with skin reaction (steroids, anti-allegics,
topical immuno-modulator, etc.) and extremely tanned
skin. The subjects were required to be clearly informed
regarding the nature of the study, the timetable, con-
straints and possible risks, both verbally and in writing.
The average age of the subjects was 38.1 years. The sub-
jects had no history of allergic contact dermatitis and
had not used topical or systemic irritant preparations in
Fig. 1 The antioxidant properties of the effect of Gaillardia aristata flower extract (GAE). Radical scavenging activity was determined using different
concentrations of GAE (25, 50, 100, 200, and 500 μg/mL) or vitamin C and trolox by DPPH (a) and ABTS+ (b). The effect of GAE was
confirmed by measurement of reducing capacity (c) and total phenolic contents (d). Data are mean ± standard deviation. **p < 0.01
compared with the vehicle-treated group (n = 3)
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the previous month. GAE (0.1 %) formulated with squa-
lene was prepared and applied. The patches (chambers)
stayed in place for 48 h. After patch removal, the condi-
tion of the skin at the patch sites were scored according to
the terminology modified from Frosch & Kligman [19]
and CTFA guidelines [20] as follows: 0 = no reaction; 1 =
slight erythema, spotty of diffuse; 2 =moderate uniform
erythema; 3 = intense erythema with ethema; 4 = intense
erythema with edema and vesicles. Reactions are evaluated
visually upon patch removal and at 30 min and 24 hours
later. All assessments were performed under standard
lighting conditions by a qualified research expert or
dermatologist. This study was approved by the ethics
committee of the DERMAPRO/Skin Research Center
(Seoul, Republic of Korea).
Statistical analysis
All data are expressed as mean ± SD. Differences
between the control and treatment groups were evaluated
by one-way ANOVA using SPSS software, version 22.0
(IBM Corporation, New York, NY, U.S.A.). A p-value <
0.01 was considered statistically significant.
Results
Antioxidant capacities of GAE
Four in vitro assays were performed to evaluate the anti-
oxidant properties of GAE (Fig. 1). Radical-scavenging
activity was assessed by the DPPH assay using vitamin C
(50 μg/mL) and trolox (50 μg/mL) for comparative control.
DPPH scavenging activity of the various concentrations of
GAE (25-500 μg/mL) ranged from 25.39 ± 0.49 % to
96.55 ± 0.00 %, with an IC50 of 74.98 ± 0.48 μg/mL
(Fig. 1a). The results indicated that free radical-
scavenging activity of GAE in a dose-dependent manner.
The ABTS+ scavenging capacity assay was performed to
determine antioxidant activity. GAE at 200 μg/mL showed
similar ABTS+ scavenging capacities as that of vitamin C
(50 μg/mL) or trolox (50 μg/mL) (Fig. 1b). The IC50 of
GAE was 110.79 ± 3.88 μg/mL. The results clearly indi-
cated the antioxidant property of GAE. To measure the
reducing activity of GAE, different concentrations of GAE
(25-500 μg/mL) or trolox (50 μg/mL) were used. GAE at
500 μg/mL exhibited similar reducing capacity as trolox
(Fig. 1c), indicating the reducing power of GAE. Total
phenolic content of GAE was measured using gallic acid as
the standard. The total phenolic content of GAE 200 μg/mL
(103.38 ± 1.02 μg/mL) was higher than that of 100 μg/mL of
gallic acid (96.21 ± 0.97 μg/mL) (Fig. 1d). This was
probably due to some bioactive compounds, such as poly-
phenols including tannins and flavonoids, in GAE.
Effect of GAE on melanin production in HEMa-DP cells
The effect of GAE on human epidermal melanocytes
proliferation was assessed using a MTT assay. Results
are expressed as percent viability relative to control. The
viability of human melanocytes treated with various
concentrations of GAE compared to kojic acid is shown
in Fig. 2a. No remarkable cytotoxicity was observed in
human melanocytes treated with 5 and 10 μg/mL GAE.
However, >20 μg/mL concentration was cytotoxic to
human melanocytes. GAE at the nontoxic concentra-
tions was used subsequently to determine the inhibition
of melanogenesis in human melanocytes. We next
performed human melanocytes were incubated with
GAE at doses of 5-20 μg/mL for 96 h to investigate the
effect GAE on melanin production. GAE produced a
dose-dependent decrease in the melanin content of
human melanocytes that exceeded the declines in kojic
acid-treated samples (Fig. 2b).
Effect of GAE on cellular tyroisnase inhibition in
HEMa-DP cells
Cellular tyrosinase activity was determined to assess the
depigmentig effect of GAE on human melanocytes
because tyrosinase is crucial in melanogenesis. Kojic acid
Fig. 2 Cell viability (a) and melanin content (b) in human epidermal
melanocytes incubated with the indicated concentration of GAE
(5, 10, 20 μg/mL). Kojic acid are used as positive controls. Data are
mean ± standard deviation. **p < 0.01 compared with the vehicle-
treated group (n = 5)
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Fig. 3 (See legend on next page.)
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was used as a comparative control. The efficacy of tyro-
sinase inhibition by GAE (20 μg/mL) and kojic acid
(60 μg/mL) was 25.62 ± 2.09 % and 19.21 ± 0.70 %, re-
spectively (Fig. 3a). Additionally, the effects of GAE on
cellular tyrosinase inhibition were determined by zymo-
graphy. GAE treatment resulted in a dose-dependent re-
duction in the cellular tyrosinase (Fig. 3b). A luciferase
reporter assay was carried out in human melanocytes to
determine the antimelanogenesis activity of GAE. GAE
inhibited tyrosinase luciferase reporter activation (Fig. 3c).
These results indicated that GAE treatment significantly
reduced cellular tyrosinase activity.
Evaluation of antimelanogenesis activity in B16F10
GAE exhibited antimelanogenesis in human epidermal
melanocytes. B16F10 melanoma cells are widely-used to
evaluate antimelanogenic effect of test materials because
they are relatively easy to culture in vitro, and they share
most of the melanogenic mechanisms of normal human
melanocytes. To demonstrate the depigmenting activity
of GAE in B16 melanoma cells, cell viability, melanin
content, and tyrosinase activity were determined.
Cytotoxicity of GAE in B16F10 cells was measured
using the MTT assay. When B16F10 cells were treated
with 0-50 μg/mL GAE no significant cytotoxic effect was
evident (Fig. 3d). Melanin levels and melanin pigmenta-
tion induced by α-MSH were reduced in a concentration-
dependent manner by GAE treatment (Fig. 3e-f). To test
whether GAE inhibited tyrosinase, a key enzyme cata-
lyzing the rate-limiting step in melanin biosynthesis,
tyrosinase zymography and tyrosinase luciferase reporter
activation assays of enzyme activity were carried out in
B16F10 melanoma cells. Tyrosinase activity in GAE-
treated and cultured B16F10 melanoma cells was
suppressed in a dose-dependent pattern (Fig. 3g-i).
Effect of GAE on melanogenesis-related proteins and
gene expression
To test whether GAE does regulate the expression of
melanogenesis-related proteins, HEMa-DP cells were
treated with GAE (10 and 20 μg/mL) for 5 days. TYR,
TRP-1, DCT, and MITF levels were assayed by Western
blot (Fig. 4a). Compared with untreated control cells,
GAE treatment at 20 μg/mL significantly reduced TYR,
TRP-1, DCT, and MITF level in a dose-dependent manner
(Fig. 4b-e). Additionally, the effects of GAE on expression
of melanogenic genes were tested using real-time PCR.
mRNA levels of MITF and its downstream genes, TYR,
TRP-1 and DCT, were reduced by GAE (Fig. 4f). GAE
may contribute to the inhibition of melanogenesis by
regulating the expression of tyrosinase-related genes as
wells as MITF.
Effect of GAE in human epidermal equivalents
To more closely approximate human usage, a recon-
structed human skin model was used to investigate the
depigmenting activity of GAE. Kojic acid was the positive
standard, consistent with its common use for skin depig-
mentation therapy. As shown in Fig. 5, the level of
melanin decreased significantly following GAE treatment.
The depigmenting activity of 200 μg/mL GAE was com-
parable to that of 2 % kojic acid.
Effect of GAE on SCF-stimulated pigmentation in human
epidermal equivalents
Hyperpigmentation causes skin darkness and medical
disorders by melanocyte activity involved in UV damage
or post-inflammation [21, 22]. Several cytokines and che-
mokines, such as SCF and endothelin-1 (ET-1), function
in hyperpigmentary mechanism related to UVB exposure
or senile lentigo [23, 24]. Therefore, we examined the
inhibition of GAE on melanogenesis induced by SCF in
normal human epidermal melanocytes. Human epidermal
equivalents were treated with GAE (100 and 200 μg/mL)
or SCF (20 nM) and skin lightening index was recorded.
The color of the human epidermal equivalents treated
with 200 μg/mL GAE was lighter than that of the
untreated control. Furthermore, the addition of SCF
gradually stimulated visible pigmentation over 14 days of
treatment. During the SCF-induced stimulation of pig-
mentation, the addition of either concentration of GAE
distinctly reduced the increase in visible pigmentation
over 14 days (Fig. 6a-b).
Human skin primary irritation test of GAE
Natural products including plant derived extracts and
naturally derived substances may have side effects such
as cutaneous irritation and allergic hypersensitivities.
(See figure on previous page.)
Fig. 3 Evaluations the effects of GAE on cellular tyrosinase activity by tyrosinase inhibition (a), zymography (b) and tyrosinase luciferase reporter
assay (c) in Human melanocyte. Human melanocytes were treated with the indicated concentrations of GAE for 5 days and then the cellular
tyrosinase activity was measured. The results are expressed relative to controls. Data are mean ± standard deviation. *p < 0.05 compared with the
vehicle-treated group, **p < 0.01 compared with the vehicle-treated group (n = 3). Cell viability (d) and melanin content (e) were determined in
B16F10 cells treated with GAE. Before measuring the melanin content, cells were observed using a contract microscope and photographed using
an attached digital camera. Cellular tyrosinase activity was measured using tyrosinase inhibition (g), L-DOPA zymography analysis (h) and tyrosinase
luciferase reporter assay (i). The results are expressed relative to controls. Data are mean ± standard deviation. ##p < 0.01 compared with the
vehicle-treated group, *p < 0.05 compared with the α-MSH-treated group, **p < 0.01compared with the α-MSH-treated group (n = 3)
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Skin primary irritation test in humans is the typical way
of determining substance safety. To evaluate the irrita-
tion effect of GAE for clinical applications to human
skin, a patch test was performed. The data of 31 subjects
was collected and analyzed. As shown in Table 1, GAE
did not show any skin reaction at 30 min and 24 h after
patch removal in all subjects. This result indicated that
GAE is safe to use as a potential alternative for cosmetic
ingredient.
Discussion
Although kojic acid and arbutin are common skin whiten-
ing products, there is a need to find safer and more effect-
ive skin lightening agents because of the carcinogenic
Fig. 4 Inhibitory effects of GAE on expression of melanogenesis-related protein and mRNA. a Western blot assay were performed to estimate protein
expression levels of b tyrosinase (TYR), c tyrosinase-related protein-1 (TRP-1), d DCT, and e MITF. Protein loading amounts were confirmed by β-actin
expression and f the mRNA levels were examined by real time RT-PCR using glyceraldehydes 3-phosphate dehydrogenase (GAPDH) as control. Data
are mean ± standard deviation. **p < 0.01 compared with the vehicle-treated group (n = 3)
Kim et al. BMC Complementary and Alternative Medicine  (2015) 15:449 Page 8 of 11
Fig. 5 GAE significantly decreases the level of melanin pigmentation in reconstructed epidermis. Reconstructed epidermis was exposed to GAE or
kojic acid for 2 weeks and pigmentation was observed upon Fontana-Masson (FM) staining. Data are mean ± standard deviation. **p < 0.01 compared
with the vehicle-treated group (n = 3)
Fig. 6 GAE-mediated inhibition of melanogenesis induced by SCF in normal human epidermal melanocytes. Reconstructed epidermis were cultured
with GAE and SCF (20 nM) for 14 days. Images were exhibited using a microscope a. L-values of cell pigmentation were measured using a chromameter
(CR-300, Minolta) b. Data are mean ± standard deviation. ##p < 0.01 compared with the vehicle-treated group, **p < 0.01 compared with the SCF-treated
group (n= 3)
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possibility of kojic acid [9, 10] and weak photostability of
arbutin [25]. In this study, GAE showed good antimelano-
genic activity similar to those of chemicals, and no adverse
skin reactions including erythema, burning, or pruritus.
Based on these results, GAE can be used as alternative
skin-lightening agent to kojic acid and arbutin.
It is necessary to confirm the effectiveness of the newly
discovered anti-melanogenesis inhibitors in a 3D skin
model. Histological change due to depigmenting effect of
GAE was observed using Fontana-Masson staining in hu-
man epidermal equivalents. GAE inhibited melanin pro-
duction more strongly than kojic aicd in human epidermal
equivalents. In addition SCF-induced melanin production
was decreased in the GAE-treated group.
Melanogenesis is regulated by keratinocyte-derived me-
diators such as α-MSH, basic fibroblastic growth factor,
SCF, ET-1. Keratinocytes also produce cytokines, such as
interleukin (IL-6) and tumor necrosis factor-α (TNF-α),
which function as paracrine inhibitors in human melano-
cytes. The mechanism of epidermal hyper-pigmentation
occurs by the increased expression level of ET-1 and SCF,
or the decreased expression of TNF-α and IL-6. In particu-
lar, SCF and ET-1 are germane to the hyper-pigmentary
mechanism by UVB-induced melanin synthesis [26–30].
Presently, GAE inhibited SCF-stimulated pigmentation in
human epidermal equivalents. SCF stimulates MITF
expression, which leads to up-regulate tyrosinase activity.
GAE inhibited MITF expression and tyrosinase activ-
ity in melanocytes. Further studies will be required to
elucidate the SCF pathway related to antimelanogenic
activity of GAE.
In this study, GAE additionally exhibited an antioxidant
effect and had reducing power. In addition, as the amount
of total phenolics of GAE (200 μg/mL) was higher than
that of gallic acid (100 μg/mL), the antioxidant capacity of
GAE perhaps derived from polyphenolic constituents of
GAE. Flavonoids including polyphenol have antioxidant
and antimelanogenic activities [31–33]. The main mech-
anism of flavonoids having the depigmenting effect may
be the ROS-scavenger properties and the ability to chelate
metals at the active site of metalloenzymes [34].
Conclusions
GAE potently inhibits melanin production by reducing
TYR, TRP-1, DCT and MITF expression in melanocytes.
This antimelanogenic effect was also confirmed in B16
melanoma cells and in a 3D skin model. In addition, GAE
has the apparent antioxidant capacity and no skin pri-
mary irritation in humans. These findings imply that
GAE can be developed as an anti-hyperpigmentation
and antioxidant agent in human skin care products.
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